IDEXX Laboratories, Inc. (BVMF:I1DX34)

Market Cap	262.79B +28.7%
Revenue (ttm)	23.70B +10.4%
Net Income	5.84B +19.3%
EPS	72.04 +22.6%
Shares Out	n/a
PE Ratio	45.03
Forward PE	43.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4
Average Volume	40
Open	654.28
Previous Close	n/a
Day's Range	648.33 - 654.28
52-Week Range	439.00 - 813.60
Beta	1.66
RSI	33.81
Earnings Date	Feb 2, 2026

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: I1DX34

Financial Performance

In 2025, IDEXX Laboratories's revenue was $4.30 billion, an increase of 10.42% compared to the previous year's $3.90 billion. Earnings were $1.06 billion, an increase of 19.33%.

Financial numbers in USD